0.8203
price down icon7.09%   -0.0626
after-market After Hours: .82 -0.0003 -0.04%
loading

Cue Biopharma Inc Stock (CUE) Forecast

The Cue Biopharma Inc (CUE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $18.84, representing a +2,196% increase from the current price of $0.8203. The highest analyst price target is $21.36, and the lowest is $16.32.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CUE Price Target
Average 13.68 (+1,567% Upside)
loading

Is Cue Biopharma Inc (CUE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 53.19 Neutral
STOCH(9,6) 54.55 Neutral
STOCHRSI(14) 28.71 Neutral
MACD(12,26) 0.0478 Buy
ADX(14) 39.05 Buy
William %R -63.55 Neutral
CCI(14) 5.1458 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.8576
Sell
0.8503
Sell
MA20
0.7937
Buy
0.8114
Buy
MA50
0.7158
Buy
0.7736
Buy
MA100
0.7827
Buy
0.8278
Sell
MA200
1.0445
Sell
0.9533
Sell
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, CUE could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on CUE, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 53.19 indicates that CUE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 54.55 indicates that CUE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.71 indicates that CUE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 39.05 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 5.1458 indicates that CUE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term CUE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Cue Biopharma Inc financial reports and earnings history, Cue Biopharma Inc (CUE) stock could reach $3.4031 by 2030, $3.8124 by 2040 and $11.89 by 2050. See the projected annual prices until 2050 of the Cue Biopharma Inc stock below:

  • Cue Biopharma Inc (CUE) is expected to reach an average price of $1.3531 in 2035, with a high prediction of $1.80 and a low estimate of $1.4631. This indicates an $64.95% rise from the last recorded price of $0.8203.
  • Cue Biopharma Inc (CUE) stock is projected to chart a bullish course in 2040, with an average price target of $2.9773, representing an $262.95% surge from its current level. The forecast ranges from a conservative $3.6973 to a sky-high $3.8124.
  • Our analysts predict Cue Biopharma Inc (CUE) to jump 971.12% by 2045, soaring from $9.0267 to an average price of $8.7864, potentially reaching $9.1398. While $9.0267 is the low estimate, the potential upside is significant.
  • Cue Biopharma Inc (CUE) stock is expected to climb by 2050, reaching an average of $11.83, a $1,342% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.89 and $12.03, respectively, highlighting the market's uncertainty.

Cue Biopharma Inc Stock (CUE) Year by Year Forecast

Cue Biopharma Inc Stock (CUE) Price Forecast for 2025

Cue Biopharma Inc Stock (CUE) is expected to reach an average price of $15.25 in 2025, with a high prediction of $26.52 and a low estimate of $3.9771. This indicates an +1,759% rise from the last recorded price of $0.8203.
Month Average Low High Change from today's price
August, 2025 $17.31 $16.32 $21.36 +2,011%
September, 2025 $14.89 $13.15 $18.59 +1,715%
October, 2025 $10.92 $9.0661 $17.55 +1,231%
November, 2025 $10.19 $9.5737 $13.55 +1,142%
December, 2025 $6.3889 $5.9989 $12.45 +678.84%

Cue Biopharma Inc Stock (CUE) Price Forecast for 2026

The predicted value for Cue Biopharma Inc (CUE) in 2026 is set at an average of $8.931. Estimates vary from a peak of $12.25 to a trough of $5.6144, indicating an +988.75% surge from the present price of $0.8203.
Month Average Low High Change from today's price
January, 2026 $9.0523 $6.2247 $9.5123 +1,004%
February, 2026 $8.6557 $7.7257 $9.804 +955.19%
March, 2026 $8.0492 $7.2974 $9.1816 +881.25%
April, 2026 $9.4785 $8.0909 $12.25 +1,055%
May, 2026 $10.01 $6.9502 $11.45 +1,121%
June, 2026 $7.9253 $6.3641 $10.37 +866.15%
July, 2026 $9.3946 $6.3988 $11.51 +1,045%
August, 2026 $9.1081 $8.6722 $10.63 +1,010%
September, 2026 $7.2074 $6.6243 $9.5539 +778.62%
October, 2026 $6.7008 $5.7482 $7.4382 +716.87%
November, 2026 $7.9842 $5.6144 $8.9442 +873.33%
December, 2026 $10.63 $7.2259 $11.85 +1,196%

Cue Biopharma Inc Stock (CUE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Cue Biopharma Inc (CUE) is $7.33, with a high forecast of $14.62 and a low forecast of $0.0397. This indicates an +793.58% increase from the last price of $0.8203.
Month Average Low High Change from today's price
January, 2027 $8.057 $7.637 $10.90 +882.20%
February, 2027 $11.03 $7.8559 $14.62 +1,245%
March, 2027 $8.0897 $6.5497 $11.08 +886.19%
April, 2027 $6.2931 $5.6631 $9.1014 +667.17%
May, 2027 $3.2866 $2.9548 $7.6048 +300.65%
June, 2027 $1.4958 $1.4358 $3.8933 +82.35%
July, 2027 $1.4293 $0.8076 $2.5076 +74.24%
August, 2027 $1.0327 $0.7227 $2.871 +25.90%
September, 2027 $0.552 $0.0397 $1.1286 -32.71%
October, 2027 $0.3346 $0.0596 $0.9237 -59.22%
November, 2027 $0.3211 $0.3587 $0.597 -60.85%
December, 2027 $0.2682 $0.3018 $0.3735 -67.31%

Cue Biopharma Inc Stock (CUE) Price Forecast for 2028

In 2028, Cue Biopharma Inc (CUE) is projected to reach an average price of $1.3613, with a high projection of $2.716 and a low estimate of $0.00667. This indicates an +65.95% rise from the last price of $0.8203.
Month Average Low High Change from today's price
January, 2028 $0.0516 $0.106 $0.334 -93.71%
February, 2028 $0.745 $0.00667 $0.3933 -9.19%
March, 2028 $0.2357 $0.2957 $0.4209 -71.27%
April, 2028 $0.6878 $0.0561 $1.1519 -16.16%
May, 2028 $0.00293 $0.1188 $1.3895 -99.64%
June, 2028 $0.8005 $0.0946 $1.0246 -2.41%
July, 2028 $0.7639 $0.5122 $1.1739 -6.87%
August, 2028 $0.1368 $0.0715 $0.8898 -83.33%
September, 2028 $0.8967 $0.1709 $1.2067 +9.31%
October, 2028 $2.4701 $0.5625 $2.60 +201.12%
November, 2028 $1.7694 $1.2578 $2.716 +115.70%
December, 2028 $1.3728 $1.2278 $1.9253 +67.36%

Cue Biopharma Inc Stock (CUE) Price Forecast for 2029

The 2029 price forecast for Cue Biopharma Inc Stock (CUE) is $1.8471 on average, with a high prediction of $3.68 and a low estimate of $0.0141. This represents an +125.17% increase from the previous price of $0.8203.
Month Average Low High Change from today's price
January, 2029 $1.6221 $1.1887 $2.6604 +97.75%
February, 2029 $0.6556 $0.4956 $1.718 -20.08%
March, 2029 $0.489 $0.4631 $0.7914 -40.39%
April, 2029 $0.0424 $0.0434 $0.5207 -94.83%
May, 2029 $0.3817 $0.0141 $0.9117 -53.46%
June, 2029 $0.5352 $0.2693 $0.8093 -34.76%
July, 2029 $0.8386 $0.5278 $1.4001 +2.23%
August, 2029 $0.9179 $0.7645 $1.4303 +11.90%
September, 2029 $0.3513 $0.2913 $0.9838 -57.17%
October, 2029 $0.3206 $0.1748 $0.7272 -60.91%
November, 2029 $0.0441 $0.0459 $0.5482 -94.63%
December, 2029 $4.21 $0.1142 $3.68 +413.23%

Cue Biopharma Inc Stock (CUE) Price Forecast for 2030

Cue Biopharma Inc Stock (CUE) is expected to reach an average price of $6.1746 in 2030, with a high forecast of $12.08 and a low forecast of $0.2684. This signifies an +652.72% surge from the last price of $0.8203.
Month Average Low High Change from today's price
January, 2030 $3.9783 $4.0248 $3.4031 +384.98%
February, 2030 $5.1145 $4.1163 $3.873 +523.50%
March, 2030 $3.6777 $3.8077 $4.1411 +348.33%
April, 2030 $3.5308 $4.2225 $3.4708 +330.43%
May, 2030 $3.0322 $2.9456 $3.2891 +269.65%
June, 2030 $3.0553 $4.0988 $3.9671 +272.47%
July, 2030 $1.2368 $2.5068 $2.7636 +50.77%
August, 2030 $4.8651 $0.2684 $6.3301 +493.09%
September, 2030 $4.737 $2.357 $6.9018 +477.47%
October, 2030 $6.2956 $3.1804 $9.6456 +667.47%
November, 2030 $1.8124 $1.3224 $12.08 +120.95%
December, 2030 $1.8893 $1.0459 $4.5659 +130.32%
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Cap:     |  Volume (24h):